Literature DB >> 22334719

Conditional inactivation of noggin in the postnatal skeleton causes osteopenia.

Ernesto Canalis1, Lisa J Brunet, Kristen Parker, Stefano Zanotti.   

Abstract

Noggin is an antagonist of bone morphogenetic proteins (BMP), and its overexpression causes suppressed osteoblastogenesis and osteopenia. Global inactivation of Noggin results in severe developmental defects and prenatal lethality, but the consequences of the conditional inactivation of Noggin on the postnatal skeleton are not known. To study the function of noggin in osteoblasts, we generated tissue-specific null Noggin mice by mating Noggin conditional mice, where the Noggin allele is flanked by loxP sequences, with mice expressing the Cre recombinase under the control of the osteocalcin promoter (Oc-Cre). Noggin conditional null mice exhibited decreased weight, shortened femoral length, and generalized osteopenia. Bone histomorphometric and microarchitectural analyses of distal femurs revealed decreased bone volume due to a reduced number of trabeculae in 1- and 3-month-old Noggin conditional null mice. Vertebral microarchitecture confirmed the osteopenia observed in Noggin conditional null mice. Osteoclast number was increased in 1-month-old male Noggin conditional null mice, and bone formation was increased in 3-month-old mice, but female mice did not exhibit increased bone remodeling. In conclusion, Noggin inactivation causes osteopenia, suggesting that BMP in excess have a detrimental effect on bone or that noggin has a BMP-independent role in skeletal homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334719      PMCID: PMC3320258          DOI: 10.1210/en.2011-1604

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  54 in total

Review 1.  Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins.

Authors:  K Miyazono
Journal:  Bone       Date:  1999-07       Impact factor: 4.398

2.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 3.  Bone morphogenetic proteins and their antagonists.

Authors:  Elisabetta Gazzerro; Ernesto Canalis
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

4.  Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.

Authors:  Mina Okamoto; Junko Murai; Hideki Yoshikawa; Noriyuki Tsumaki
Journal:  J Bone Miner Res       Date:  2006-07       Impact factor: 6.741

5.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton.

Authors:  L J Brunet; J A McMahon; A P McMahon; R M Harland
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

6.  Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis.

Authors:  Y Gong; D Krakow; J Marcelino; D Wilkin; D Chitayat; R Babul-Hirji; L Hudgins; C W Cremers; F P Cremers; H G Brunner; K Reinker; D L Rimoin; D H Cohn; F R Goodman; W Reardon; M Patton; C A Francomano; M L Warman
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

7.  Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.

Authors:  Elisabetta Gazzerro; Renata C Pereira; Vanda Jorgetti; Sarah Olson; Aris N Economides; Ernesto Canalis
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

8.  Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling.

Authors:  Valerie Deregowski; Elisabetta Gazzerro; Leah Priest; Sheila Rydziel; Ernesto Canalis
Journal:  J Biol Chem       Date:  2006-01-06       Impact factor: 5.157

9.  C/EBP homologous protein is necessary for normal osteoblastic function.

Authors:  Renata C Pereira; Lisa Stadmeyer; Stefan J Marciniak; David Ron; Ernesto Canalis
Journal:  J Cell Biochem       Date:  2006-02-15       Impact factor: 4.429

10.  Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex.

Authors:  B Frenkel; C Capparelli; M Van Auken; D Baran; J Bryan; J L Stein; G S Stein; J B Lian
Journal:  Endocrinology       Date:  1997-05       Impact factor: 4.736

View more
  14 in total

1.  Systemic injection of CK2.3, a novel peptide acting downstream of bone morphogenetic protein receptor BMPRIa, leads to increased trabecular bone mass.

Authors:  Hemanth Akkiraju; Jeremy Bonor; Kristine Olli; Chris Bowen; Beth Bragdon; Harold Coombs; Leah Rae Donahue; Randall Duncan; Anja Nohe
Journal:  J Orthop Res       Date:  2014-10-20       Impact factor: 3.494

2.  Dynamics and cellular localization of Bmp2, Bmp4, and Noggin transcription in the postnatal mouse skeleton.

Authors:  Steven K Pregizer; Douglas P Mortlock
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

3.  Expression of Noggin and Gremlin1 and its implications in fine-tuning BMP activities in mouse cartilage tissues.

Authors:  Xiaodan Yu; Hiroko Kawakami; Naoyuki Tahara; Merissa Olmer; Shinichi Hayashi; Ryutaro Akiyama; Anindya Bagchi; Martin Lotz; Yasuhiko Kawakami
Journal:  J Orthop Res       Date:  2016-11-08       Impact factor: 3.494

4.  A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.

Authors:  Marc Baud'huin; Nicolas Solban; Milton Cornwall-Brady; Dianne Sako; Yoshimi Kawamoto; Katia Liharska; Darren Lath; Mary L Bouxsein; Kathryn W Underwood; Jeffrey Ucran; Ravindra Kumar; Eileen Pobre; Asya Grinberg; Jasbir Seehra; Ernesto Canalis; R Scott Pearsall; Peter I Croucher
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-03       Impact factor: 11.205

Review 5.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

6.  The effect of noggin interference in a rabbit posterolateral spinal fusion model.

Authors:  E Klineberg; D R Haudenschild; K D Snow; S Garitty; B A Christiansen; C Acharya; S Maitra; M C Gupta
Journal:  Eur Spine J       Date:  2014-04-17       Impact factor: 3.134

7.  BMP signaling in mesenchymal stem cell differentiation and bone formation.

Authors:  Maureen Beederman; Joseph D Lamplot; Guoxin Nan; Jinhua Wang; Xing Liu; Liangjun Yin; Ruidong Li; Wei Shui; Hongyu Zhang; Stephanie H Kim; Wenwen Zhang; Jiye Zhang; Yuhan Kong; Sahitya Denduluri; Mary Rose Rogers; Abdullah Pratt; Rex C Haydon; Hue H Luu; Jovito Angeles; Lewis L Shi; Tong-Chuan He
Journal:  J Biomed Sci Eng       Date:  2013-08

8.  Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease.

Authors:  Pelin O Simsek Kiper; Hiroaki Saito; Francesca Gori; Andrea Superti-Furga; Roland Baron; Sheila Unger; Eric Hesse; Kei Yamana; Riku Kiviranta; Nicolas Solban; Jeff Liu; Robert Brommage; Koray Boduroglu; Luisa Bonafé; Belinda Campos-Xavier; Esra Dikoglu; Richard Eastell; Fatma Gossiel; Keith Harshman; Gen Nishimura; Katta M Girisha; Brian J Stevenson; Hiroyuki Takita; Carlo Rivolta
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

Review 9.  Regulation of tissue morphogenesis by endothelial cell-derived signals.

Authors:  Saravana K Ramasamy; Anjali P Kusumbe; Ralf H Adams
Journal:  Trends Cell Biol       Date:  2014-12-17       Impact factor: 20.808

10.  Endothelial Notch activity promotes angiogenesis and osteogenesis in bone.

Authors:  Saravana K Ramasamy; Anjali P Kusumbe; Lin Wang; Ralf H Adams
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.